Abstract
1. We studied the acute haemodynamic effects of cromakalim, a vasodilator which activates smooth muscle potassium channels, in 11 patients with ischaemic heart disease undergoing routine cardiac catheterisation. A similar group of six patients given placebo were studied under identical conditions. 2. There were no significant differences in baseline haemodynamic parameters between the two groups. 3. Following intravenous cromakalim (15 micrograms kg-1) cardiac output increased by 30% (P less than 0.05 vs placebo) while systolic arterial pressure decreased by 8% (P less than 0.05), systemic vascular resistance decreased by 29% (P less than 0.01) and pulmonary vascular resistance decreased by 24% (P less than 0.01) at plasma concentrations of the (+)- and (-)-enantiomers of cromakalim of 6.2 +/- 0.5 ng ml-1 and 10.0 +/- 1.0 ng ml-1 respectively. 4. There were no significant differences in diastolic arterial pressure, left ventricular dP/dt and stroke volume between the two groups. Heart rate increased by 11% following cromakalim but this did not achieve significance. 5. These findings confirm that cromakalim acts primarily as an arteriolar vasodilator producing an improvement in cardiac performance. Cromakalim may be of benefit in the treatment of patients with ischaemic heart disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bolton T. B., Clapp L. H. The diverse effects of noradrenaline and other stimulants on 86Rb and 42K efflux in rabbit and guinea-pig arterial muscle. J Physiol. 1984 Oct;355:43–63. doi: 10.1113/jphysiol.1984.sp015405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buckingham R. E., Clapham J. C., Hamilton T. C., Longman S. D., Norton J., Poyser R. H. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):798–804. doi: 10.1097/00005344-198709010-00022. [DOI] [PubMed] [Google Scholar]
- Cook N. S., Quast U., Hof R. P., Baumlin Y., Pally C. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol. 1988 Jan;11(1):90–99. doi: 10.1097/00005344-198801000-00014. [DOI] [PubMed] [Google Scholar]
- Culling W., Ruttley M. S., Sheridan D. J. Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease. Br Heart J. 1984 Oct;52(4):431–434. doi: 10.1136/hrt.52.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLeay R. A., Stallard T. J., Watson R. D., Littler W. A. The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation. 1983 May;67(5):1084–1090. doi: 10.1161/01.cir.67.5.1084. [DOI] [PubMed] [Google Scholar]
- Sheridan D. J., Thomas P. Vascular versus myocardial selectivity of calcium antagonists. J Cardiovasc Pharmacol. 1987;10 (Suppl 1):S165–S168. doi: 10.1097/00005344-198710001-00030. [DOI] [PubMed] [Google Scholar]
- Weir S. W., Weston A. H. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol. 1986 May;88(1):121–128. doi: 10.1111/j.1476-5381.1986.tb09478.x. [DOI] [PMC free article] [PubMed] [Google Scholar]